Trial Profile
Phase II trial of Captisol-enabled topiramate injection for the treatment of epilepsy and seizures in hospitalised patients
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 16 Aug 2013
Price :
$35
*
At a glance
- Drugs Topiramate (Primary)
- Indications Partial epilepsies; Tonic-clonic epilepsy
- Focus Therapeutic Use
- Sponsors CURx Pharmaceuticals
- 16 Aug 2013 New trial record